ASM Policy efforts focus on communicating the importance of the microbial science to Congress, Federal Agencies and the Public. 

What's New in Public Policy?

Prev Next

October 17, 2016 - ASM, AMP and PASCV Express Concerns On New Molecular Test for Zika

The ASM, the Association for Molecular Pathology (AMP) and Pan American Society for Clinical Virology (PASCV) ask for data and clarification on the rRT-PCR assay for the testing of Zika, dengue and chikungunya viruses.


Clinical Microbiology Issues Update - October 2016

The October issue of the Clinical Microbiology Issues Update has been published by the Office of Public Affairs.


e-Public Policy Update – October 2016

The Office of Public Affairs has published the October issue of the e-Public Policy Update


Minority Microbiology Mentor Newsletter - October 2016

The October issue of the Minority Microbiology Mentor has been published by the Committee on Microbiological Issues Impacting Minorities (CMIIM)


October 3, 2016 - White Paper on the Emergence of mcr-1 Plasmid-Mediated Colistin Resistance

The Committee on Laboratory Practices has developed a white paper to update members on colistin resistance and testing.


September 29, 2016 - Congress Passes Short-term Continuing Resolution and Funds Zika Response

The ASM Office of Public Affairs has summarized the details of the Continuing Resolution that includes funding to combat Zika.


ASM Acts to Counter Zika Virus Outbreak

A key role of a scientific association is to make the voices of its many individual members heard as a unified whole. Speaking on behalf of its 47,000 members worldwide, ASM has acted quickly to make the case to policy makers that we must take immediate and aggressive action against...